Actual Medicinal Product (AMP) Half Sinemet CR 25mg/100mg tablets (DE Pharmaceuticals)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
- Notes
-
Complex dosing regime. Protect from moisture. Max 7 days in MCA.
- Provenance
-
This compatibility recommendation is derived from Half Sinemet CR 25mg/100mg tablets (Organon Pharma (UK) Ltd) and Caramet 25mg/100mg CR tablets (Teva UK Ltd).
- Generic
- Co-careldopa
- Formulation
- Co-careldopa 25mg/100mg modified-release tablets
-
Co-careldopa
-
Co-careldopa 25mg/100mg modified-release tablets
-
Half Sinemet CR 25mg/100mg tablets (DE Pharmaceuticals)
-
-